Asymmetric Dimethylarginine in Cerebral Small Vessel Disease
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background and Purpose— Endothelial dysfunction may play a causal role in cerebral small vessel disease (SVD). Asymmetric dimethylarginine (ADMA), a circulating endogenous inhibitor of nitric oxide, has been implicated in endothelial dysfunction, particularly in hyperhomocystinemia, a known risk factor for SVD. We determined if ADMA was elevated in SVD, correlated with disease severity, and interacted with homocysteine. Methods— ADMA and homocysteine levels were determined in 47 consecutive symptomatic SVD patients and 38 controls. SVD was graded by leukoariosis severity and number of lacunar infarcts. Results— Mean (and SD) ADMA was higher in SVD patients compared with controls (0.814 [0.145] versus 0.747 [0.184] μmol/L; P =0.014) after controlling for age, gender, vascular risk factors, and creatinine clearance. Additionally controlling for homocysteine had only a small effect on this relationship ( P =0.055). Mean homocysteine was higher in SVD cases compared with controls (15.14 [5.59] versus 12.49 [4.15] μmol/L; P =0.035). Leukoariosis grade correlated positively with ADMA ( P =0.026) and homocysteine ( P =0.003). Lacunar grade correlated with homocysteine ( P =0.017), but not ADMA. Conclusions— ADMA is independently associated with SVD and correlates with leukoariosis severity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
Self-citation
Cited by
Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review
Poggesi, A., Pasi, M., Pescini, F., Pantoni, L., & Inzitari, D. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.116 · Cited by 253
Crosstalk between the nervous system and the kidney
Tanaka, S., & Okusa, M. D. (2020) · Kidney International · doi:10.1016/j.kint.2019.10.032 · Cited by 160
Endothelial dysfunction in lacunar stroke: a systematic review
Knottnerus, I. L. H., Ten Cate, H., Lodder, J., Kessels, F., & van Oostenbrugge, R. J. (2009) · Cerebrovascular Diseases · doi:10.1159/000212672 · Cited by 137
Pikula, A., Böger, R. H., Beiser, A. S., Maas, R., DeCarli, C., Schwedhelm, E., Himali, J. J., Schulze, F., Au, R., Kelly-Hayes, M., et al. (2009) · Stroke · doi:10.1161/strokeaha.109.557116 · Cited by 85
Genes, endothelial function and cerebral small vessel disease in man
Markus, H. S. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.038752 · Cited by 76
“There are significant risk factor differences between the two subtypes, suggesting that they do indeed represent different pathologies, with hypertension being particularly important for the leukoaraiosis subtype (Khan et al. 2007b).”
BackgroundSelf-citation
Metadata
- Authors
- Khan, U., Hassan, A., Vallance, P., & Markus, H. S.
- Venue
- Stroke
- Published
- 2007-02
- Volume
- 38
- Issue
- 2
- Pages
- 411-413
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2004750472
- Cited by
- 58
- References
- 1
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Asymmetric Dimethylarginine in Cerebral Small Vessel Disease. https://app.cochat.ai/papers/10.1161/01.str.0000254500.27412.ac
- The paper
- Khan, U., Hassan, A., Vallance, P., & Markus, H. S. (2007). Asymmetric Dimethylarginine in Cerebral Small Vessel Disease. Stroke. https://doi.org/10.1161/01.str.0000254500.27412.ac
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.